Cargando…
Curcumin as a Modulator of P-Glycoprotein in Cancer: Challenges and Perspectives
Multidrug resistance (MDR) presents a serious challenge to the efficiency of cancer treatment, and may be associated with the overexpression of drug efflux pumps. P-glycoprotein (P-gp) is a drug efflux pump often found overexpressed in cases of acquired MDR. Nevertheless, there are no P-gp inhibitor...
Autores principales: | Lopes-Rodrigues, Vanessa, Sousa, Emília, Vasconcelos, M. Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198046/ https://www.ncbi.nlm.nih.gov/pubmed/27834897 http://dx.doi.org/10.3390/ph9040071 |
Ejemplares similares
-
Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies
por: Lopes, Ana, et al.
Publicado: (2018) -
Curcumin Regulates Colon Cancer by Inhibiting P-Glycoprotein in In-situ Cancerous Colon Perfusion Rat Model
por: Neerati, Prasad, et al.
Publicado: (2013) -
Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
por: Veiga-Matos, Jéssica, et al.
Publicado: (2023) -
Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives
por: Xu, Xiao-Yu, et al.
Publicado: (2018) -
Probing the Allosteric
Modulation of P-Glycoprotein:
A Medicinal Chemistry Approach Toward the Identification of Noncompetitive
P-Gp Inhibitors
por: Bonito, Cátia A., et al.
Publicado: (2023)